Navigation Links
Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
Date:5/15/2012

Treatments for Idiopathic Toe Walking Based on Child's Age and Severity of Gait Abnormality

Most children develop a normal walking pattern, or gait, by age 2. And while some toe walkingwhere a child primarily walks on the front of the foot or toes, never touching the heel to the groundis common, persistent toe walking beyond age 2 may indicate a neurological disorder.

A review article, "Idiopathic Toe Walking," outlines the appropriate steps for effectively diagnosing and treating pediatric toe walking when the cause of the disorder is unknown. A comprehensive physical examination should focus on the child's lower extremities and his or her gait pattern to rule out any neurodevelopmental disorders, and take into consideration the child's medical history including the details of gestation, birth, early development and other medical events. Electromyopathy (measuring the conducting function of muscles and nerves) and gait kinematics (study of human motion) can further identify abnormalities. Treatment is based on physical examination results and the age of the child. For patients under age 2, initial treatment may simply be observation as many children eventually develop a normal heel-toe gait on their own.

Non-surgical treatments often are recommended for younger children in whom the muscles have not become overly tight and may include physical therapy to stretch the posterior calf muscle, braces and night splints to stretch the heel cord and stabilize ankle movement, or a walking cast below the knee. If nonsurgical treatments are unsuccessful, surgical lengthening of the calf muscle may be recommended. All treatment decisions should have the full support of and input from the child's parents.

Strategies for Treating Patients with Continued Pain, Limited Function Following Rotator Cuff Surgery

Most patients (more than 90 percent) with rotator cuff tears experience successful outcomes following surgery, including decreased pain, increased active range of motion (ROM), and improved shoulder strength function following surgery.

A review article, "Management of Failed Arthroscopic Rotator Cuff Repair," outlines potential treatment and pain management options for the estimated small percentage of patients who continue to experience pain, weakness and limited mobility following surgery. For these patients, the study recommends a thorough physical examination to rule out any other causes for the pain, weakness and/or limited mobility, such as cervical spine disease or a subsequent, secondary trauma to the shoulder. Standard radiographs of the shoulder also should be obtained. Occasionally, advanced imaging, such as an MRI or an Ultrasound, may be warranted.

In some cases, treatment options may include repair, partial repair, partial repair with biologic or synthetic substances, or a tendon transfer. Candidates for revision surgery and repair are typically younger than age 65, without signs of arthritis, pseudoparalysis (voluntary paralysis), tendon retraction, or muscle atrophy. Tendon transfers, where the muscles and tendons of the shoulder are moved for rotator cuff deficiency, are a salvage option for younger patients, often with good results.

Read about "A Nation in Motion" and what Mary Bennett, Patricia McConaghy, Terry Dewald, and others can now do since their rotator cuff surgeries. Patient interview opportunities are available.


'/>"/>

Contact: Kayee Ip
ip@aaos.org
847-384-4035
American Academy of Orthopaedic Surgeons
Source:Eurekalert

Related medicine news :

1. Stethoscope App gives iPhone New Clinical Skills
2. Sunquest Introduces Integrated Clinical Environment Physician Portal Solution in US
3. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
4. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
5. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
6. NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
7. UCLA Health System Presents: How to Successfully Implement a Clinical Portal
8. TeraMedica Launches Evercore – Clinical Enterprise Suite 5.0 Now on Linux
9. Mesothelioma Clinical Trials List Offered by IQ Mesothelioma: Search Current Mesothelioma Treatment Options
10. MedQuist Launches EHR Integration for Dictations Associated with Template-based Clinical Documentation
11. Greenway Medical Technologies Donates Electronic Health Record, Clinical Research and Revenue Cycle Solutions to Northern Kentucky University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... , June 24, 2016 ... has announced the addition of the " Global ... This report ... provides an updated review, including its applications in various ... total market, which includes three main industries: pharmaceutical and ...
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
Breaking Medicine Technology: